ST.
PAUL, Minn., Aug. 4, 2022
/PRNewswire/ -- 3M Health Care's
Medical Solutions Division has advanced the delivery of 3M™
Veraflo™ Therapy. A new 3M™ Veraflo™ Cleanse Choice Complete™
Dressing Kit and a software upgrade for the 3M™ V.A.C.®
Ulta Therapy Unit was introduced at no increase cost to the
customer. These new offerings help simplify the care delivery
processes for clinicians using Veraflo Therapy (negative pressure
wound therapy with instillation) and help make dressing changes
easier, faster, and less painful for their patients as compared to
previous Veraflo Therapy dressings.
Wound care experts use Veraflo Therapy for patients with open
soft tissue wounds to help cleanse and stimulate formation of
granulation tissue. A recent publication by Gabriel et al
Effects of Negative-Pressure Wound Therapy with Instillation
versus Standard of Care in Multiple Wound Types: Systematic
Literature Review and Meta-Analysis, shows that Veraflo Therapy
demonstrated significant clinical advantages and economic savings
versus other advanced wound therapies, including traditional
negative pressure wound therapy (NPWT). When Veraflo Cleanse Choice
Complete Dressing is used in conjunction with Veraflo Therapy, the
combination helps to disrupt, soften, solubilize and remove thick,
exudate and non-viable tissue when immediate wound cleansing is
needed or when surgical debridement must be delayed or is not
possible.
"3M offers a broad range of wound
care solutions because clinicians need a robust tool selection,"
said Ronald Silverman, M.D.,
3M Health Care senior vice president
of clinical affairs and chief medical officer. "We continue to find
ways to innovate to meet their unique wound care needs and address
the changing nature of wound care. Today's wound care patients are
often sicker and have more comorbidities, making their wounds more
complex to treat and increasing the demands on clinicians' time. We
strive to make our products easier to use to help save clinicians'
valuable time and, ultimately, transform patient outcomes and
improve their lives."
Software upgrade
The V.A.C.® Ulta Therapy Unit is the only negative
wound pressure therapy device that delivers four therapy options,
enabling clinicians in the acute care setting to manage open
abdomens, closed incisions, and open soft tissue wounds across a
wide range of complexities, including size, contamination, and
etiology.
The device's newly upgraded software, which includes the 3M™
Smart Instill™ Feature for use with Veraflo Therapy, automates
therapy initiation and makes it easier for clinicians to initiate
therapy. Additional upgraded functionalities include animated video
troubleshooting, an instill phase postpone feature, a therapy
inactive alarm time delay providing clinicians a choice to delay
alarms during dressing changes, along with the updated default
therapy settings. These new default settings are based on the
recommendations of a global panel of wound care leaders as outlined
in a 2020 NPWT with instillation consensus guidelines update
document published in International Wound Journal. Kim PJ, Attinger
CE, Constantine, T et al. Int Wound J.2020;17:174–186.
"Veraflo Therapy with Smart Instill Feature helps remove the
guesswork and difficult aspects of setting up NPWT with
instillation for patients. You push a button or two and the
software guides you through the decision-making process,
significantly decreasing the time involved in administering the
therapy," said Marc Matthews, MD,
MS, MCG, FACS, Arizona Burn Center associate director.
The software upgrade has been completed in all US rental units.
Owned units will be upgraded beginning in 3Q22.
Dressing kit
Based on clinician feedback, the new Veraflo Choice Cleanse
Complete Dressing Kit was developed to simplify dressing
application and reduce the number of SKUs and ancillary products
used to manage open soft tissue wounds. The kit's new dressing is a
single piece, which users may find easier to apply than the current
three-piece dressing. The three-piece dressing is still an
available option for users who are accustomed to this design. This
kit is also the first time the 3M™ Dermatac™ Drape is included in a
Veraflo Therapy Dressing Kit. Dermatac Drape is constructed
of a unique silicone-acrylic hybrid material that is gentler than
acrylic drapes on patients' skin at removal, leading to less
painful dressing changes. During application the drape can also be
repositioned, which simplifies clinicians' efforts.
The combination of the Smart Instill Feature and the Veraflo
Cleanse Choice Complete Dressing Kit make Veraflo Therapy easier
than ever to apply. Now, clinicians can choose a more innovative
therapy option, without the challenge of increased complexities or
costs while positively impacting the patient's experience. For more
information visit www.3M.com/Veraflo.
About 3M NPWT
3M launched NPWT in 1994 and has
been a global category leader ever since. 3M NPWT products are trusted in over 60,000
hospitals, homes, and businesses worldwide. More than 10 million
wounds have been treated worldwide with 3M™ V.A.C.®
Therapy and more than 75% of published NPWT clinical evidence is
based on V.A.C.® Therapy. 3M's comprehensive portfolio
of advanced wound care solutions is backed by clinical evidence
across new and growing categories such as dressings, disposables,
digital technology and connectivity.
About 3M
3M (NYSE: MMM) believes science
helps create a brighter world for everyone. By unlocking the power
of people, ideas and science to reimagine what's possible, our
global team uniquely addresses the opportunities and
challenges of our customers, communities, and planet. Learn
how we're working to improve lives and make what's
next at 3M.com/news or
on Twitter at @3M or @3MNews.
NOTE: Specific indications, contraindications, warnings,
precautions, and safety information exist for these products and
therapies. Please consult a clinician and product instructions for
use prior to application. Rx only
View original content to download
multimedia:https://www.prnewswire.com/news-releases/3m-upgrades-make-negative-pressure-wound-therapy-with-instillation-easier-for-clinicians-to-initiate-301599675.html
SOURCE 3M